The Rs 175.06 crore Annu Projects IPO entered its third day of bidding on August 27, with the issue subscribed 47% on Day 2. The IPO has attracted stronger retail participation, while its grey market premium (GMP) stands at around Rs 4, indicating a potential listing gain of about 4%. With the issue closing on August 28, investors are tracking subscription trends and GMP ahead of the listing.
Symbiotec Pharmalab IPO enters its final bidding day with 5.31 times overall subscription and a Rs 285 GMP. The Rs 1,757 crore issue is priced at Rs 938–988 per share, with listing expected on September 1. Proceeds will partly repay debt, while investors weigh strong demand against premium valuation and risks.
Forecasts suggest that by mid-2027, Indian equity markets may be trading lower compared to the beginning of 2026. This trend is driven by foreign investors shifting their focus to more promising Asian markets that offer better value and opportunities in AI. Although overseas investors have sold off considerable amounts of Indian stocks this year, domestic investors continue to back the market with systematic investment strategies.
Tyagi, however, remains cautious on pockets of the mid- and small-cap universe, where valuations are above long-term averages. He sees large caps as relatively more attractive on valuations, while advocating selective, bottom-up stock-picking in the broader market. Edited Excerpts
Following the allotment, shares for successful applicants are expected to be credited to their demat accounts ahead of the company’s market debut. Augmont Enterprises is scheduled to list on both the BSE and NSE on August 31, 2026.
PNB Housing Finance shares have seen significant gains this year. The company is focusing on affordable and emerging housing segments. This strategic shift aims to improve its valuation and return ratios. Disbursements and net profit are expected to grow robustly in coming years. Stable asset quality and new financing initiatives support future growth.
Lumino Industries plans a ₹700 crore initial public offering to reduce debt and boost manufacturing capacity. The company expects to benefit from increased demand for wires and cables. However, its debt has risen significantly due to expansion and working capital needs. Raw material price volatility and customer concentration present key operational risks. The issue is suitable for long-term investors with higher risk tolerance.
Salesforce raised its fiscal 2027 revenue and adjusted earnings forecasts, signaling stronger demand for its AI-powered autonomous agents. The company expects revenue of $46.1 billion to $46.4 billion, while annual adjusted EPS guidance also increased. Salesforce shares jumped 7% in extended trading as investors welcomed accelerating AI adoption and growth prospects.
US corporate profit margins reached a record 19.4% in the second quarter, up from 18.2%, as profits jumped nearly 10%. Strong consumer spending and companies passing higher prices on to customers supported earnings. Business investment also remained robust, with nonresidential fixed investment rising at an annualized 8.5% pace.
Anthropic is preparing for a potential major Wall Street debut, fueled by rapid growth in AI coding through Claude Code. However, massive cash requirements, heavy losses, political tensions and fierce competition could test investor confidence in its long-term business model.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.